FdaApplication

ANDA 219919

Back to search

Identifiers

Properties

PropertyValue
applicant_nameNOVITIUM PHARMA LLC
application_typeANDA
approval_date2026-02-02

Products (4)

ProductActive ingredientStrengthDosage form
MIRTAZAPINEMIRTAZAPINE7.5MGTABLET;ORAL
MIRTAZAPINEMIRTAZAPINE45MGTABLET;ORAL
MIRTAZAPINEMIRTAZAPINE15MGTABLET;ORAL
MIRTAZAPINEMIRTAZAPINE30MGTABLET;ORAL

4 products